Commensal bacteria produce GPCR ligands that mimic human signaling molecules

• Published in: Nature (London) Vol. 549; no. 7670; pp. 48 - 53
• Main Authors: Cohen, Louis J., Esterhazy, Daria, Kim, Seong-Hwan, Lemetre, Christophe, Aguilar, Rhiannon R., Gordon, Emma A., Pickard, Amanda J., Cross, Justin R., Emiliano, Ana B., Han, Sun M., Chu, John, Vila-Farres, Xavier, Kaplitt, Jeremy, Rogoz, Aneta, Calle, Paula Y., Hunter, Craig, Bitok, J. Kipchirchir, Brady, Sean F.
• Format: Journal Article
• Language: English
• Published: 30.08.2017
• ISSN: 0028-0836; 1476-4687
• DOI: 10.1038/nature23874

Commensal bacteria are believed to play important roles in human health. The mechanisms by which they affect mammalian physiology are poorly understood; however, bacterial metabolites are likely to be key components of host interactions. Here, we use bioinformatics and synthetic biology to mine the human microbiota for N -acyl amides that interact with G-protein-coupled receptors (GPCRs). We found that N -acyl amide synthase genes are enriched in gastrointestinal bacteria and the lipids they encode interact with GPCRs that regulate gastrointestinal tract physiology. Mouse and cell-based models demonstrate that commensal GPR119 agonists regulate metabolic hormones and glucose homeostasis as efficiently as human ligands although future studies are needed to define their potential physiologic role in humans. This work suggests that chemical mimicry of eukaryotic signaling molecules may be common among commensal bacteria and that manipulation of microbiota genes encoding metabolites that elicit host cellular responses represents a new small molecule therapeutic modality (microbiome-biosynthetic-gene-therapy).